https://www.ibcomms.agency/releases25/title21-health-solutions-joins-blood-and-cells-advocacy-roster%E2%80%99s-(bcar)-think-tank-consortium 2026-02-05 https://www.ibcomms.agency/releases25/exmoor-pharma-and-ucl-forge-a-strategic-collaboration-to-speed-the-advancement-of-cell-and-gene-therapies 2026-02-05 https://www.ibcomms.agency/releases25/appleton%E2%80%99s-community-blood-center-helps-strengthen-platelet-supply-with-fda-approved-automation-from-terumo-blood-and-cell-technologies 2026-02-05 https://www.ibcomms.agency/releases25/exmoor-pharma-and-royal-free-london-launch-strategic-collaboration-to-strengthen-uk-cell-and-gene-therapy-manufacturing-pathway 2026-02-05 https://www.ibcomms.agency/releases25/university-of-chicago-school-of-medicine-achieves-first-ever-automated-3-in-1-tcr-t-manufacturing-on-terumo-blood-and-cell-technologies-quantum-flex-bioreactor 2026-02-05 https://www.ibcomms.agency/releases25/ib-communications-and-ibtv-partner-with-advanced-therapies-usa-to-showcase-advanced-therapies-innovation-for-2025-event%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-appoints-liza-loidolt-as-general-manager-of-cell-and-gene-therapy-business%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-and-santersus-ag-collaborate-on-therapeutic-apheresis-technology-for-sepsis-treatment%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/scaleready-announces-a-g-rex%C2%AE-grant-has-been-awarded-to-sonoma-biotherapeutics%C2%A0%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/ibtv-and-aabb-partner-to-spotlight-the-future-of-blood-and-biotherapies-at-2025-annual-meeting%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/scaleready-announces-multiple-g-rex%C2%AE-grants-have-been-awarded-to-leading-investigators-at-children's-national-hospital 2026-02-05 https://www.ibcomms.agency/releases25/the-blood-center-in-new-orleans-modernizes-platelet-processing-with-fda-cleared-automation-from-terumo-blood-and-cell-technologies%E2%80%A8 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-and-hemex-health-join-forces-to-improve-outcomes-for-millions-with-sickle-cell-disease-and-other-hemoglobin-disorders%C2%A0- 2026-02-05 https://www.ibcomms.agency/releases25/adva-biotechnology-and-autolomous-launch-the-digital-pioneer-program-to-enable-decentralized%2C-scalable-cell-therapy-manufacturing-%E2%80%94-gencart-inc.-joins-as-first-clinical-participant 2026-02-05 https://www.ibcomms.agency/releases25/kenya%2C-uganda-and-c%C3%B4te-d%E2%80%99ivoire-partner-with-terumo-blood-and-cell-technologies-to-build-coordinated-national-care-frameworks-for-sickle-cell-care%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/vitalant-launches-national-service-hubs-to-expand-patient-access-to-cell-and-gene-therapies 2026-02-05 https://www.ibcomms.agency/releases25/reithera-to-showcase-innovative-viral-vector-platforms-at-esgct-2025 2026-02-05 https://www.ibcomms.agency/releases25/exmoor-pharma-and-siam-bioscience-form-strategic-partnership-to-establish-leading-cell-and-gene-therapy-services-in-southeast-asia 2026-02-05 https://www.ibcomms.agency/releases25/scaleready-awards-g-rex%C2%AE-grants-to-support-cell-and-gene-therapy-manufacturing-in-california 2026-02-05 https://www.ibcomms.agency/releases25/csl-plasma-and-terumo-blood-and-cell-technologies-announce-completion-of-nationwide-rollout-of-rika-plasma-donation-system%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-supports-expanded-access-to-rare-disease-therapies-in-latin-america- 2026-02-05 https://www.ibcomms.agency/releases25/cellprothera-announces-peer-reviewed-publication-of-its-phase-i%2Fiib-results-on-safety-and-feasibility-of-protheracytes%C2%AE-in-patients-with-severe-heart-failure-post-myocardial-infarction%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/title21-hosts-inaugural-advisory-council-meeting-to-drive-development-of-interoperable-cgt-software-tools%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/exmoor-pharma-and-anthony-nolan-cell-therapy-and-laboratory-services-to-offer-end-to-end-support-for-cell-therapy-developers 2026-02-05 https://www.ibcomms.agency/releases25/terumo-bct-and-pwc-belgium-join-forces-to-break-barriers-in-access-to-advanced-cell-and-gene-therapies%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/vitalant-and-upmc-expand-partnership-to-advance-cell-and-gene-therapy-initiatives 2026-02-05 https://www.ibcomms.agency/releases25/adva-biotechnology-and-autolomous-announce-collaboration-to-co-lead-the-digital-pioneer-program-for-scalable-autologous-cell-therapy-manufacturing 2026-02-05 https://www.ibcomms.agency/releases25/scaleready-announces-a-g-rex%C2%AE-grant-has-been-awarded-to-sidra-medicine 2026-02-05 https://www.ibcomms.agency/releases25/reithera-contributes-gmp-manufacturing-and-vector-platform-to-phase-1-hiv-vaccine-trial-in-africa 2026-02-05 https://www.ibcomms.agency/releases25/phase-1-clinical-trial-of-hiv-vaccine-starts-in-africa-to-evaluate-immune-responses-to-highly-networked-hiv-t-cell-epitopes 2026-02-05 https://www.ibcomms.agency/releases25/scaleready-announces-multiple-g-rex%C2%AE-grants-have-been-awarded-to-investigators-at-university-of-minnesota's-center-for-genome-engineering 2026-02-05 https://www.ibcomms.agency/releases25/leriglitazone-marketing-authorization-application-submitted-for-treatment-of-cerebral-adrenoleukodystrophy-has-been-validated-by-european-medicines-agency 2026-02-05 https://www.ibcomms.agency/releases25/likarda-launches-%22predictive-polymer-analytics%E2%84%A2%22-%E2%80%94-a-breakthrough-ai-platform-revolutionizing-complex-therapy-formulation-and-encapsulation 2026-02-05 https://www.ibcomms.agency/releases25/vivebiotech-appoints-patricio-massera-as-president 2026-02-05 https://www.ibcomms.agency/releases25/cellprothera-collaborator-presents-phase-1%2F2b-quality-of-life-results-for-protheracytes%C2%AE-cell-therapy-at-isth%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-demonstrates-integrated-3-in-1-car-t-workflow-using-its-quantum-platform 2026-02-05 https://www.ibcomms.agency/releases25/advanced-therapies-think-tank-launches-with-powerhouse-faculty-ahead-of-first-episode-on-cgt-in-community-healthcare 2026-02-05 https://www.ibcomms.agency/releases25/scaleready-awards-multiple-g-rex%C2%AE-grants-to-leading-investigators-at-the-university-of-southern-california-(usc)-and-the-children's-hospital-of-los-angeles-(chla) 2026-02-05 https://www.ibcomms.agency/releases25/erratum%3A-cellprothera-selects-cellforcure-by-seqens-for-phase-3-gmp-manufacturing%E2%80%AF 2026-02-05 https://www.ibcomms.agency/releases25/exmoor-pharma-and-ku-leuven-announce-strategic-partnership-to-accelerate-cell-and-gene-therapy-innovation-through-new-venture 2026-02-05 https://www.ibcomms.agency/releases25/reithera-to-present-five-posters-and-introduce-new-u.s.-business-development-lead-at-asgct-2025 2026-02-05 https://www.ibcomms.agency/releases25/join-parachute-implementing-terumo-blood-and-cell-technologies%E2%80%99-rika-plasma-donation-system-to-enhance-donor-experience-and-help-expand-access-to-lifesaving-therapies 2026-02-05 https://www.ibcomms.agency/releases25/nextcell-cso-lindsay-davies-honoured-with-multiple-new-leadership-roles-within-european-cell-therapy-community 2026-02-05 https://www.ibcomms.agency/releases25/america%E2%80%99s-blood-centers-joins-blood-and-cells-advocacy-roster%E2%80%99s-(bcar)-think-tank-consortium 2026-02-05 https://www.ibcomms.agency/releases25/title21-names-advisory-committee-to-build-cell-therapy-expertise 2026-02-05 https://www.ibcomms.agency/releases25/king-faisal-specialist-hospital-%26-research-centre-and-germfree-laboratories-announce-landmark-advanced-therapy-manufacturing-campus-in-riyadh 2026-02-05 https://www.ibcomms.agency/releases25/exmoor-pharma-and-signadori-bio-launch-partnership-to-develop-next-generation-monocyte-based-cell-therapy-for-solid-tumours 2026-02-05 https://www.ibcomms.agency/releases25/scaleready-announces-a-g-rex%C2%AE-grant-has-been-awarded-to-immuneel-therapeutics 2026-02-05 https://www.ibcomms.agency/releases25/axio-biopharma-and-likarda-announce-strategic-partnership-to-accelerate-biologic-drug-development-and-delivery 2026-02-05 https://www.ibcomms.agency/releases25/nextcell-announces-strategic-collaboration-with-fujifilm-irvine-scientific 2026-02-05 https://www.ibcomms.agency/releases25/cellprothera-to-present-protheracytes%C2%AE-clinical-data-and-receive-a-stem-cell-engineering-abstract-award-for-phase-i%2Fiib-results-at-isct-2025-scientific-annual-meeting-in-new-orleans 2026-02-05 https://www.ibcomms.agency/releases25/%C2%A0likarda-announces-peer-reviewed-publication-highlighting-hydrogel-encapsulation-with-css-can-overcome-major-obstacle-of-liver-cell-therapies 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-names-patrick-daly-as-chief-business-officer 2026-02-05 https://www.ibcomms.agency/releases25/registration-now-open-for-advanced-therapies-europe-2025-%E2%80%93-where-innovation-meets-opportunity 2026-02-05 https://www.ibcomms.agency/releases25/title21-health-solutions-names-jonathan-wofford-chief-commercial-officer 2026-02-05 https://www.ibcomms.agency/releases25/cellprothera-announced-new-board-of-directors%3A-capabilities-to-enhance-development-and-commercialization-plan 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-partners-with-south-korea%E2%80%99s-kbiohealth-to-help-develop-nation%E2%80%99s-cell-and-gene-therapy-workforce%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/ib-communications-partners-with-terrapinn-for-advanced-therapies-congress-in-london%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/reithera-to-unveil-reicell-aav-platform-for-high-efficiency-gene-therapy-aav-production%2C-adding-to-mva-and-grad-vector-capabilities 2026-02-05 https://www.ibcomms.agency/releases25/likarda-receives-grant-to-deliver-antibody-secreting-cell-therapy-with-css%C2%AE-hydrogel-encapsulation 2026-02-05 https://www.ibcomms.agency/releases25/pragmatrix-technology-partners-with-achieve-clinics-to-transform-cell-therapy-workflows-with-the-praglife-platform 2026-02-05 https://www.ibcomms.agency/releases25/minoryx-announces-dosing-of-the-first-patient-with-leriglitazone-in-the-phase-2a-study-in-rett-syndrome-(tree-study) 2026-02-05 https://www.ibcomms.agency/releases25/working-together-for-a-sustainable-future%3A-b%C3%BCrkert-fluid-control-systems-and-green-elephant-biotech 2026-02-05 https://www.ibcomms.agency/releases25/cellprothera-presenting-at-advanced-therapies-congress-2025-in-london-%C2%A0-ibon-garitaonandia%2C-cellprothera's-cso%2C-will-present-on-%E2%80%9Cdevelopment-of-cell-based-therapies-for-post-acute-myocardial-infarction.%E2%80%9D%C2%A0 2026-02-05 https://www.ibcomms.agency/releases25/national-alliance-of-sickle-cell-centers-and-terumo-blood-and-cell-technologies-working-together-to-improve-outcomes-for-patients-with-sickle-cell-disease 2026-02-05 https://www.ibcomms.agency/releases25/carter-bloodcare-first-to-complete-the-transition-to-automated-whole-blood-processing-with-terumo-blood-and-cell-technologies 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-highlights-the-future-of-blood-in-davos-interviews-2025-film-series 2026-02-05 https://www.ibcomms.agency/releases25/phacilitate-awards-katherine-high-with-the-2025-lifetime-achievement-award-at-the-advanced-therapies-awards-ceremony-in-dallas 2026-02-05 https://www.ibcomms.agency/releases25/reithera-and-sillajen-partnership-announced 2026-02-05 https://www.ibcomms.agency/releases25/catalent-announces-collaboration-with-galapagos-to-further-expand-galapagos%E2%80%99-decentralized-car-t-manufacturing-network-in-the-u.s. 2026-02-05 https://www.ibcomms.agency/releases25/terumo-blood-and-cell-technologies-and-fujifilm-irvine-scientific-collaborate-to-accelerate-t-cell-expansion-for-cell-therapy-developers%C2%A0%C2%A0 2026-02-05